Global Advanced Therapies for Blood Purification Market - 2025-2033

August 2025 | 74 pages | ID: G4395E91185EEN
DataM Intelligence

Abstracts

Global Advanced Therapies for Blood Purification Market reached US$ 3.78 Billion in 2024 and is expected to reach US$ 7.37 Billion by 2033, growing with a CAGR of 7.80% during the forecast period 2026-2033.

The Global Advanced Therapies for Blood Purification Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Global Advanced Therapies for Blood Purification Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Therapy Type

• Hemodialysis*
• Hemofiltration
• Plasmapheresis
• Hemoperfusion
• Continuous Renal Replacement Therapy (CRRT)
• Extracorporeal Membrane Oxygenation (ECMO)
• Others

By Application

• End-Stage Kidney Disease*
• Acute Kidney Injury
• Multi-Organ Failure
• Sepsis & Septic Shock
• Toxicological Emergencies
• Autoimmune Disorders
• Others

By End-User

• Hospitals*
• Specialty Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Others

Regional Analysis for Global Advanced Therapies for Blood Purification Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Global Advanced Therapies for Blood Purification Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Therapy Type
2.4. Snippet by Application
2.5. Snippet by End-User
2.6. Snippet by Region

3. DYNAMICS

3.1. Impacting Factors
  3.1.1. Drivers
    3.1.1.1. Rising Chronic and Acute Disease Burden
    3.1.1.2. Surging Home-Care and Portable Device Demand
  3.1.2. Restraints
    3.1.2.1. Procedure-Related Risks and Complications
    3.1.2.2. High Equipment and Treatment Costs
  3.1.3. Opportunity
    3.1.3.1. Home-Based & Portable Purification Systems
    3.1.3.2. Emergence of Bioartificial Kidneys & Regenerative Platforms
  3.1.4. Impact Analysis

4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

4.1. Market Leaders and Pioneers
  4.1.1. Emerging Pioneers and Prominent Players
  4.1.2. Established Leaders with the Largest Marketing Brand
  4.1.3. Market Leaders with Established Products
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
  4.3.1. North America
  4.3.2. Europe
  4.3.3. Asia Pacific
  4.3.4. South America
  4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Patent Analysis
4.6. Unmet Needs and Gaps
4.7. Recommended Strategies for Market Entry and Expansion
4.8. Pricing Analysis and Price Dynamics

5. ADVANCED THERAPIES FOR BLOOD PURIFICATION MARKET, BY THERAPY TYPE

5.1. Introduction
  5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
  5.1.2. Market Attractiveness Index, By Therapy Type
5.2. Hemodialysis*
  5.2.1. Introduction
  5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Hemofiltration
5.4. Plasmapheresis
5.5. Hemoperfusion
5.6. Continuous Renal Replacement Therapy (CRRT)
5.7. Extracorporeal Membrane Oxygenation (ECMO)
5.8. Others

6. ADVANCED THERAPIES FOR BLOOD PURIFICATION MARKET, BY APPLICATION

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  6.1.2. Market Attractiveness Index, By Application
6.2. End-Stage Kidney Disease*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Acute Kidney Injury
6.4. Multi-Organ Failure
6.5. Sepsis & Septic Shock
6.6. Toxicological Emergencies
6.7. Autoimmune Disorders
6.8. Others

7. ADVANCED THERAPIES FOR BLOOD PURIFICATION MARKET, BY END-USER

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  7.1.2. Market Attractiveness Index, By End-User
7.2. Hospitals*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Specialty Clinics
7.4. Ambulatory Surgical Centers
7.5. Homecare Settings
7.6. Others

8. ADVANCED THERAPIES FOR BLOOD PURIFICATION MARKET,BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

9. INTRODUCTION

9.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  9.1.1. Market Attractiveness Index, By Region
9.2. North America
  9.2.1. Introduction
  9.2.2. Key Region-Specific Dynamics
  9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
  9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.2.6.1. U.S.
    9.2.6.2. Canada
    9.2.6.3. Mexico
9.3. Europe
  9.3.1. Introduction
  9.3.2. Key Region-Specific Dynamics
  9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
  9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.3.6.1. Germany
    9.3.6.2. UK
    9.3.6.3. France
    9.3.6.4. Spain
    9.3.6.5. Italy
    9.3.6.6. Rest of Europe
9.4. Asia-Pacific
  9.4.1. Introduction
  9.4.2. Key Region-Specific Dynamics
  9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
  9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.4.6.1. China
    9.4.6.2. India
    9.4.6.3. Japan
    9.4.6.4. South Korea
    9.4.6.5. Rest of Asia-Pacific
9.5. South America
  9.5.1. Introduction
  9.5.2. Key Region-Specific Dynamics
  9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
  9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.5.6.1. Brazil
    9.5.6.2. Argentina
    9.5.6.3. Rest of South America
9.6. Middle East and Africa
  9.6.1. Introduction
  9.6.2. Key Region-Specific Dynamics
  9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
  9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

11. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS

11.1. Market Share Analysis and Positioning Matrix
11.2. Strategic Partnerships, Mergers & Acquisitions
11.3. Key Developments in Product Portfolios and Innovations
11.4. Company Benchmarking

12. COMPANY PROFILES

12.1. Fresenius Medical Care AG*
  12.1.1. Company Overview
  12.1.2. Product Portfolio
    12.1.2.1. Product Description
    12.1.2.2. Product Key Performance Indicators (KPIs)

13. FINANCIAL OVERVIEW

13.1. Company Revenue
  13.1.1. Geographical Revenue Shares
    13.1.1.1. Revenue Forecasts
  13.1.2. Key Developments
    13.1.2.1. Mergers & Acquisitions
    13.1.2.2. Key Product Development Activities
    13.1.2.3. Regulatory Approvals, etc.
    13.1.2.4. SWOT Analysis
13.2. Baxter
13.3. B. Braun SE
13.4. Nikkiso Belgium BV
13.5. Asahi Kasei Medical Co., Ltd.
13.6. Medtronic
13.7. Aethlon Medical, Inc. (LIST NOT EXHAUSTIVE )

14. ASSUMPTIONS AND RESEARCH METHODOLOGY

14.1. Data Collection Methods
14.2. Data Triangulation
14.3. Forecasting Techniques
14.4. Data Verification and Validation

15. APPENDIX

15.1. About Us and Services
15.2. Contact Us